Abstract
Romosozumab (Evenity(R)), a humanized monoclonal antibody, promotes bone formation and inhibits bone resorption by inhibiting sclerostin, a protein in......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
